O9 Survival with newly-diagnosed metastatic prostate cancer in the “docetaxel era”: Data from around 700 patients in the control arm of the STAMPEDE trial (NCT00268476) (original) (raw)

Academia.edu no longer supports Internet Explorer.

To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.